Ehling U H, Charles D J, Favor J, Graw J, Kratochvilova J, Neuhäuser-Klaus A, Pretsch W
Mutat Res. 1985 Jun-Jul;150(1-2):393-401. doi: 10.1016/0027-5107(85)90136-8.
The multiple endpoint mammalian mutagenesis approach developed in our institute screens in the same animal for recessive specific-locus alleles at 7 loci, approximately 30 loci coding for dominant-cataract mutations, 23 loci controlling protein-charge changes and 12 loci for enzyme-activity alterations. Experiments to screen for the approximately 70 loci in the same offspring of treated male mice were performed with ethylnitrosourea (ENU), procarbazine and X-ray exposure. Mutations were recovered for each genetic endpoint in all treatment groups where a sufficient number of offspring was scored. ENU treatment is highly effective in inducing mutations to all genetic endpoints. The mutations were confirmed by breeding tests. The mutation rates to specific-locus and enzyme-activity alleles were both higher than the mutation rates to either dominant-cataract or protein-charge alleles. The advantages and possibilities of the multiple endpoint approach are discussed in detail.
我们研究所开发的多终点哺乳动物诱变方法,在同一只动物中筛选7个位点的隐性特异性位点等位基因、约30个编码显性白内障突变的位点、23个控制蛋白质电荷变化的位点以及12个酶活性改变的位点。用乙基亚硝基脲(ENU)、丙卡巴肼和X射线照射对经处理的雄性小鼠的同一子代进行筛选约70个位点的实验。在所有评分了足够数量子代的治疗组中,每个遗传终点都检测到了突变。ENU处理在诱导所有遗传终点的突变方面非常有效。通过育种试验证实了这些突变。特异性位点和酶活性等位基因的突变率均高于显性白内障或蛋白质电荷等位基因的突变率。详细讨论了多终点方法的优点和可能性。